BRIEF-Kiadis Pharma FY operating loss narrows to 11.4 million euros
March 31 Kiadis Pharma NV:
* Kiadis pharma announces annual results for the year ended december 31, 2016
* Cash position decreased to 14.6 million euros at year-end 2016 compared to 28.7 million euros at end of 2015
* FY net loss 14.8 million euros ($15.80 million) versus loss of 16.5 million euros year ago
* FY operating loss of 11.4 million euros versus loss of 16.0 million euros year ago Source text for Eikon: Further company coverage: ($1 = 0.9368 euros) (Gdynia Newsroom)